This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Kallio, K.A. E. Articles by Pussinen, P. J. Search for Related Content PubMed PubMed Citation Articles by Kallio, K.A. E. Articles by Pussinen, P. J. Social Bookmarking                         What's this?

Lipopolysaccharide associates with pro-atherogenic lipoproteins in periodontitis patients

Institute of Dentistry, University of Helsinki, and Department of Oral and Maxillofacial Diseases, Helsinki University Central Hospital, Helsinki, Finland, elisa.kallio{at}helsinki.fi

Kåre Buhlin

Division of Periodontology, Institute of Odontology, Karolinska Institutet, Huddinge, Sweden

Matti Jauhiainen

Department of Molecular Medicine, National Public Health Institute, Helsinki, Finland

Ritva Keva

Institute of Dentistry, University of Helsinki, and Department of Oral and Maxillofacial Diseases, Helsinki University Central Hospital, Helsinki, Finland

Anita M. Tuomainen

Institute of Dentistry, University of Helsinki, and Department of Oral and Maxillofacial Diseases, Helsinki University Central Hospital, Helsinki, Finland

Björn Klinge

Division of Periodontology, Institute of Odontology, Karolinska Institutet, Huddinge, Sweden

Anders Gustafsson

Division of Periodontology, Institute of Odontology, Karolinska Institutet, Huddinge, Sweden

Pirkko J. Pussinen

Division of Periodontology, Institute of Odontology, Karolinska Institutet, Huddinge, Sweden

Introduction: Periodontitis patients are known to suffer from endotoxemia, which may be among the major risk factors for atherosclerosis. In health, lipopolysaccharide (LPS) is mainly carried with high density lipoprotein (HDL) particles. Shift of LPS toward lipoproteins with lower densities may result in less effective endotoxin scavenging. Our aim was to determine plasma LPS activity and lipoprotein-distribution before and after treatment in periodontitis patients.

Patients and Methods: Very low and intermediate density (VLDL-IDL), low density (LDL), HDL ₂, HDL₃, and lipoprotein-deficient plasma (LPDP) were isolated by sequential ultracentrifugation. Patients included 34 subjects aged 53.5 ± 8.3 years, before and 6 months after periodontal treatment.

Results: The mean LPS distribution decreased among lipoprotein classes as follows: VLDL-IDL 41.3 ± 12.1%, LPDP 25.0 ± 7.0%, HDL₃ 13.1 ± 5.2%, LDL 11.5 ± 3.7%, and HDL₂ 9.2 ± 2.8%. Plasma and VLDL-IDL-associated LPS correlated positively, and LDL- and HDL-associated LPS negatively with clinical periodontal parameters and plasma cytokine concentrations. Mean plasma LPS activity increased after periodontal treatment from 44.0 ± 17.0 to 55.7 ± 24.2 EU/ml (P = 0.006). No significant changes were found in LPS lipoprotein distribution and lipoprotein compositions after the treatment.

Conclusions: Endotoxemia increases with severity of periodontitis. In periodontitis, LPS associates preferentially with the pro-atherogenic VLDL-IDL fraction. Periodontal treatment has only minor effects on plasma LPS activity or distribution, which reflects persistence of the disease.

Key Words: Infection • inflammation • lipoproteins • lipoprotein subclasses • periodontal disease • teeth

Innate Immunity, Vol. 14, No. 4, 247-253 (2008)
DOI: 10.1177/1753425908095130


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				M. Nymark, P. J. Pussinen, A. M. Tuomainen, C. Forsblom, P.-H. Groop, M. Lehto, and on behalf of the FinnDiane Study Group Serum Lipopolysaccharide Activity Is Associated With the Progression of Kidney Disease in Finnish Patients With Type 1 Diabetes Diabetes Care, September 1, 2009; 32(9): 1689 - 1693. [Abstract] [Full Text] [PDF]

				E. A. Nicu, M. L. Laine, S. A. Morre, U. Van der Velden, and B. G. Loos Soluble CD14 in periodontitis Innate Immunity, April 1, 2009; 15(2): 121 - 128. [Abstract] [PDF]